Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.

about

The effects of arterial flow on platelet activation, thrombus growth, and stabilization.Importance of pharmacokinetic studies in the management of acquired factor X deficiency.Long-term prophylaxis in severe factor VII deficiency.Recurrent Bleedings in Newborn: A Factor VII Deficiency Case Report.

P2860

Q38106013-45449BDA-52CE-44B2-A4DE-A7ACBA429476 Q38381686-725C7504-F341-4B7D-9A2D-E381BC9E3C34 Q40963322-1175C6DF-FC5D-4736-8694-85661E3E87CF Q55239812-A3B5FEDC-9E1C-4D9A-8654-610D7C27B843

P2860

Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.

Item

http://www.wikidata.org/entity/Q45881838

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@en

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@nl

type

Item

label

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@en

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@nl

prefLabel

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@en

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@nl

P1476

Recombinant FVIIa concentrate- ...... orders other than hemophilias.

@en

P2093

Anna Maria Lombardi

http://www.w3.org/2001/XMLSchema#string

Antonio Girolami

http://www.w3.org/2001/XMLSchema#string

Emanuela Bonamigo

http://www.w3.org/2001/XMLSchema#string

Giulia Berti de Marinis

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant factor VIIa in the treatment of bleeding.

Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records

Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications

Use of recombinant factor VIIa in hereditary bleeding disorders.

Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.

Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Recombinant activated factor VII in the treatment of non-haemophilia patients: physician under-reporting of thromboembolic adverse events.

Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.

First 20 years with recombinant FVIIa (NovoSeven).

P304

346-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/1607845412Y.0000000027

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22980722

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.

about

P2860

P2860

Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921